These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35502462)

  • 1. The safety of rapid infusion levetiracetam: A systematic review.
    Jense A; Douville A; Weiss A
    Pharmacotherapy; 2022 Jun; 42(6):495-503. PubMed ID: 35502462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution.
    Price L; Garrity L; Stiehl S
    Pharmacotherapy; 2024 Feb; 44(2):141-148. PubMed ID: 38050327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical considerations for rapid administration of undiluted or minimally diluted levetiracetam bolus doses.
    Reinert JP; Maktabi L; Branam D; Snyder M
    Expert Rev Neurother; 2022 Mar; 22(3):231-236. PubMed ID: 35240911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Tolerability of Intravenous Push Lacosamide and Levetiracetam.
    Ragoonanan D; Tran N; Levesque M
    J Pharm Pract; 2023 Oct; 36(5):1056-1060. PubMed ID: 35348010
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid administration of undiluted intravenous levetiracetam.
    Haller JT; Bonnin S; Radosevich J
    Epilepsia; 2021 Aug; 62(8):1865-1870. PubMed ID: 34164804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid administration of undiluted loading doses of levetiracetam.
    Martinez S; Bonnin SS; Radosevich J; Haller JT
    Epilepsia; 2024 Mar; 65(3):615-619. PubMed ID: 38116700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Safety Outcomes of Undiluted Levetiracetam Intravenous Push Compared to Intravenous Piggyback.
    Shim A; Radparvar S; Davis N; Kaplan A; Kantaris K; Devlin A; Liang J; Ciummo F
    J Pharm Pract; 2024 Jun; 37(3):722-727. PubMed ID: 37231709
    [No Abstract]   [Full Text] [Related]  

  • 8. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Time to Administration, Benzodiazepine Use, and Safety of Intravenous Push Levetiracetam in a Neuro-Spine Intensive Care Unit.
    Adams T; Greathouse K
    Neurocrit Care; 2021 Dec; 35(3):789-793. PubMed ID: 34081297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Dalziel SR; Borland ML; Furyk J; Bonisch M; Neutze J; Donath S; Francis KL; Sharpe C; Harvey AS; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Kochar A; Brabyn C; Oakley E; Babl FE;
    Lancet; 2019 May; 393(10186):2135-2145. PubMed ID: 31005386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous levetiracetam in Thai children and adolescents with status epilepticus and acute repetitive seizures.
    Khongkhatithum C; Thampratankul L; Wiwattanadittakul N; Visudtibhan A
    Eur J Paediatr Neurol; 2015 Jul; 19(4):429-34. PubMed ID: 25800343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the Safety and Tolerability of Rapid Administration of Undiluted Intravenous Levetiracetam in Pediatrics.
    Giannaccini C; Almendras C; Li I; DiNapoli M; Macnow T
    J Child Neurol; 2024 Jun; 39(7-8):241-245. PubMed ID: 38798130
    [No Abstract]   [Full Text] [Related]  

  • 13. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study.
    Dalziel SR; Furyk J; Bonisch M; Oakley E; Borland M; Neutze J; Donath S; Sharpe C; Harvey S; Davidson A; Craig S; Phillips N; George S; Rao A; Cheng N; Zhang M; Sinn K; Kochar A; Brabyn C; Babl FE;
    BMC Pediatr; 2017 Jun; 17(1):152. PubMed ID: 28641582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study.
    Wheless JW; Clarke D; Hovinga CA; Ellis M; Durmeier M; McGregor A; Perkins F
    J Child Neurol; 2009 Aug; 24(8):946-51. PubMed ID: 19264738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam for seizure prevention in brain tumor patients: a systematic review.
    Nasr ZG; Paravattil B; Wilby KJ
    J Neurooncol; 2016 Aug; 129(1):1-13. PubMed ID: 27168191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety and tolerability of different intravenous administrations of levetiracetam, bolus versus infusion, in intensive care unit patients.
    Burakgazi E; Bashir S; Doss V; Pellock J
    Clin EEG Neurosci; 2014 Apr; 45(2):89-91. PubMed ID: 24357676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of Intravenous Push Levetiracetam Compared to Intravenous Piggyback at a Tertiary Academic Medical Center: A Retrospective Analysis.
    Alkazemi A; McLaughlin KC; Chan MG; Schontz MJ; Anger KE; Szumita PM
    Drug Saf; 2022 Jan; 45(1):19-26. PubMed ID: 34716562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children.
    Besli GE; Yuksel Karatoprak E; Yilmaz S
    Epilepsy Behav; 2020 Oct; 111():107289. PubMed ID: 32702655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study.
    Ramael S; Daoust A; Otoul C; Toublanc N; Troenaru M; Lu ZS; Stockis A
    Epilepsia; 2006 Jul; 47(7):1128-35. PubMed ID: 16886975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.